openPR Logo
Press release

Biosimulation Market Report Focuses Major Eminent Players like Rhenovia Pharma Ltd., Dassault Systemes SA, Chemical Computing Group, Inc., Advanced Chemistry Development, Inc., Certara USA, Inc., Simulation Plus, Inc., Schrodinger, Inc., Entelos, Inc., Ph

09-17-2018 01:06 PM CET | Health & Medicine

Press release from: Crystal Market Research - Healthcare

Biosimulation Market

Biosimulation Market

A research study titled, “Biosimulation Market by Product, Application, and End User - Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that the biosimulation market is projected to be around $4 billion by 2025.

Major Eminent Players:
Some of the leading players in biosimulation market are,
Certara USA, Inc.
Dassault Systèmes SA
Accelrys, Compugen
Rhenovia Pharma
Lead Scope Inc.
Simulations Plus, Inc.
Evidera, Inc.

The competitive market for biosimulation is driven by strategic collaborations and acquisitions by leading players to strengthen their research and development capabilities and to expand their existing product portfolio. For instance, in late December 2015, Certaraacquired XenologiQ, a UK based quantitative systems pharmacology (QSP) firm, to strengthen its modeling and simulation capabilities.

For more information, click on the below link @ .

Market Scenario:
A typical drug discovery and development cycle, which encompasses the time taken for discovery of a new drug and its delivery to the market, may easily take up to 10 to 15 years. The process of drug discovery which starts with discovering a new drug molecule to registering the drug for marketing and commercialization is a very lengthy and complex process. A heavy capital investment, a considerable amount of time and series of clinical trials are required before a drug is registered for human use. FDA launched the Critical Path Initiative (CPI), in 2004, to promote innovation in scientific processes by which medical products are developed, examined and manufactured.

Biosimulation is one such promising notion to drug discovery and development. It has been developed in order to avoid the hurdles in discovery and development of a new drug by traditional processes. It promises tremendous benefits saving both money and time and improves the predictability in early stage of the drug development. In biosimulation, the relationships between different biological elements are represented using differential equations utilizing simulation techniques to predict the behavior of the biological system and status of biological elements over time.

Rise in cases of chronic diseases such as diabetes, high drug resistance exhibited by certain disease related pathogens, and rapidly aging population worldwide are some of the factors encouraging biosimulation market. Moreover, high drug failure rate and availability of advanced modeling and simulation tools will further contribute to the market growth.

In 2016, the software segment accounted for over half of the global market,due to the high accuracy of computer modeling in biosimulation to improve drug molecules. In terms of applications, the drug discovery marketis expected to show an impressive growth rate over the forecast period due to the benefits of biosimulation processesin assisting the researchers in identifying critical gaps that hamper the drug discovery process.

Pharmaceutical and biotechnology companiessegment held more than half of the global market in 2016. This large share can be attributed to the rising acceptance of in silico models (biological experiments performed entirely by means of a computer) for drug discovery and development. Large numbers of pharmaceutical and biotechnology companies are aggressively using computer models to create more advanced and effective drug variants. For example, in January 2017, Certara, the global biosimulation drug development company, announced the release of version 16 of its Simcyp Population-based Simulator, which is one of the most sophisticated platforms to determine first in-human dose selection.

Click to Request a Sample @ .

Regional Insights:
U.S. accounted for the major share of the North American market in 2016, due to the high prevalence of chronic diseases, rapidly growing elderly population, which is more prone to these diseases and are in need of treatment options such as drugs, and strategic collaborations among leading players. For instance, Certara in September 2016 acquired Australia based d3 Medicine to strengthen their ability to deliver optimized drug development plans to their clients.Also, there is rise in research activities on biosimulation in the region which will facilitate the market growth. For instance, in April 2016, Certara launched an e-learning platform under Certara University to facilitate education in the field of biosimulation and model based drug development. Emerging economies in Asia-Pacific biosimulation market will exhibit the fastest growth in the forecast period due to emphasis on research and development initiatives and rising focus of international playerson the emerging markets. For instance, in January 2016, Certara launched a strategic drug development consulting company in China, named, Certara Strategic Consulting.

Table of Contents:
1. Introduction
2. Executive Summary
3. Market Overview
4. Biosimulation Market, By Product
5. Biosimulation Market, By Application
6. Biosimulation Market, By End User
7. Biosimulation Market, By Region
8. Company Profiles

Buy now Biosimulation Market Report @ .

Key Findings of the Research Study:
The biosimulation market will be majorly driven by rise in chronic disease incidence such as cancer and diabetes, increasing prevalence of geriatric population, high drug resistance by certain disease related pathogens and high drug failure rate.

The services segment will exhibit favorable growth over the forecast period as more and more pharmaceutical companies are beginning to outsource their biosimulation processes in order to reduce costs and focus on core competencies.

North America held a major share of the biosimulation market in 2016, commanding over more than half of the market. Due to presence of highly skilled professionals and research infrastructure along with presence of regulatory authorities ensuring patient safety, this market will show promising growth over the forecast period.

Asia-Pacific market will exhibit the fastest growth rate during the forecast period due to rapidly improving healthcare infrastructure and growing Healthcare IT expenditure.

List of Tables:
Table 1.Global Biosimulation Market, By Product, 2016-2025 ($Million)
Table 2.Services Market, By Type, 2016-2025 ($Million)
Table 3.Services Market, By Region, 2016-2025 ($Million)
Table 4.In-house Services Market, By Region, 2016-2025 ($Million)
Table 5.Contract Services Market, By Region, 2016-2025 ($Million)
Table 6.Software Market, By Region, 2016-2025 ($Million)
Table 7.Global Biosimulation Market, By Application, 2016-2025 ($Million)

Market Opportunities:
There is a continuous rise in the demand for advanced software programs, which will provide ample growth opportunities for players operating in the global market. Technological advancements such as gene analysis, sequencing and coding, development of advanced mathematical model for biological assays and new methods of cell-based assays are expected to provide profitable market growth in coming years.

Ask Questions to Expertise at @ .

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customised research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimulation Market Report Focuses Major Eminent Players like Rhenovia Pharma Ltd., Dassault Systemes SA, Chemical Computing Group, Inc., Advanced Chemistry Development, Inc., Certara USA, Inc., Simulation Plus, Inc., Schrodinger, Inc., Entelos, Inc., Ph here

News-ID: 1242351 • Views: 155

More Releases from Crystal Market Research - Healthcare

Viral Vector And Plasmid Dna Manufacturing Market Outlook 2019 | Business Develo …
Crystal Market Research Present Advance research on - Viral Vector And Plasmid Dna Manufacturing Market, approximates that the Viral Vector And Plasmid Dna Manufacturing Industry size is anticipated to flourish at a significant CAGR in the future. The Viral Vector and Plasmid DNA Manufacturing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Viral vectors and plasmid DNA manufacturing usually incorporates
Medical Digital Imaging Systems Market | Research Report 2019-2025 | Major Compa …
Crystal Market Research Present Advance research on "Medical Digital Imaging Systems Market", approximates that the Medical Digital Imaging Systems Industry size is anticipated to flourish at a significant CAGR in the future. The Medical Imaging is the process and technique of making the visual portrayals of the inside of the body for the purpose of medical intervention and clinical analysis, just as visual portrayal of the functioning of certain tissues (physiology)
Medical Device Complaint Management Market | Research Report 2019-2025 | Major C …
Crystal Market Research Present Advance research on "Medical Device Complaint Management Market", approximates that the Medical Device Complaint Management Industry size is anticipated to flourish at a significant CAGR in the future. The manufacturers of medical gadget must keep record and also track the complaints of customer as per the Quality System Regulation (QSR) characterized in the 21 CFR Part 820. Furthermore, the FDA Part 803 guidelines need the firms
Veterinary Molecular Diagnostics Market | Research Report 2019-2025 | Major Comp …
The Universal Veterinary Molecular Diagnostics Market is anticipated to observe supported development over the foreseen period. The major development factor for the growth of Veterinary Molecular Diagnostics is the positive development in the beverage sector. Moreover, expanding canned food preference and increment in extra cash of the customers is the primary factors which are driving the market. Moreover, high recovery and recycling rate of the metal cans is anticipated to

All 5 Releases

More Releases for Biosimulation

Global Biosimulation Market to witness digitized satiation
In the process of biosimulation, the computer aided mathematical models are used to simulate the biological processes. Biosimulation is an important part of systems biology and helps in the discovery and development of new drugs, in the area of drug metabolism and in the modeling of biomedical systems that are complex. There is a growing demand for reduction in the cost of discovery of new drugs and the risk of failure
The Biosimulation Market to Be Driven By Neurotechnology
The Biosimulation Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future. In the process
The Biosimulation Market to stick to digitized innovation
The Biosimulation Market taught to grow sporadically shortly. With improvement in machine-powered analytics, the healthcare vertical is bound to substantiate therein. Machine learning does make caregivers able of putting data to use, thereby enhancing patients’ outcomes along with overall efficiency. This would be the trend in the healthcare vertical going forward. Get Sample Copy of this Report@ In the process of biosimulation, the computer aided mathematical models are used to simulate
Biosimulation Market Study: An Emerging Hint of Opportunity
Latest released the research study on Global Biosimulation Market, offers a detailed overview of the factors influencing the global business scope. Biosimulation Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Biosimulation. The study covers emerging player’s data, including: Certara, L.P., Simulations Plus,
Biosimulation Market Growth and Sales Forecast 2016 - 2014
Global Biosimulation Market: Overview Biosimulation refers to the mathematical simulation of biological processes and systems. It is aided by computer and is used for model based calculation of biological systems and processes. TMR’s latest report forecasts strong growth for the global biosimulation market between 2011 and 2018. The market is expected to significantly gain from the increasing use of pharmacokinetic (PKPD) and pharmacodynamics, of which PKPD is the most widely used
Biosimulation Market Size, Industry Analysis & Forecast Report 2017
Biosimulation Market Outlook To 2024 has added the report, “Biosimulation Market Outlook To 2024: Key Categories (Software, Services), by Application, by End-Use, Regional Segmentation, Pipeline Analysis, Competitive Dynamics, And Segment Forecast” extend across over 103 pages, the far reaching research study offers a 360-degree analysis of the market crosswise over different unequivocal elements, including market share by segmentation type, cost analysis, market effect factors, and marketing strategy and promoting methodology. The